RxDoctor Payments Data

Vida McGhee-Lewis, MD

Obstetrics & Gynecology · Highland, INNPI 1083696397

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (50.3%), other and food and beverage — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 84.7% of it on its own, with 26 other manufacturers making up the rest. Reporting peaked in 2021 at $12,443 and has fallen 96.6% since, to $425 in 2025. Among obstetrics & gynecology clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$17,903in general payments, 2019–2025

Across 118 payments — averaging $151.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$15K
  • Hologic Sales And Service, LLC$626
  • AbbVie$497
  • Astellas Pharma US Inc$273
  • AstraZeneca$214
  • Sumitomo Pharma America, Inc.$194
  • plus $928 from 21 others

What the payments were for

  • Food & beverage$2,90316%
  • Education$9,00050%
  • Other$6,00034%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,903 in reported general payments places this provider in the 95th percentile of 743 obstetrics & gynecology providers in Indiana.

See all obstetrics & gynecology providers in Indiana

Medicare billing

Part B allowed, 2024
$12,298
Medicare patients
48
Services billed
132

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
PremarinEstrogens, Conjugated13$5,635
Estradiol12$688
Terconazole13$218
Fluconazole24$104
Metronidazole12$94
Misoprostol13$12

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerPremarin$121$5,63513 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 743 obstetrics & gynecology providers in Indiana.

Other obstetrics & gynecology in Highland

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →